Cargando…

Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients

Detalles Bibliográficos
Autores principales:	Yevgi, Recep, Bilge, Nuray, Şimşek, Fatma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Eurasian Journal of Medicine 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184048/ https://www.ncbi.nlm.nih.gov/pubmed/34177306 http://dx.doi.org/10.5152/eurasianjmed.2021.20364

Ejemplares similares

Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy
por: Bilge, Nuray, et al.
Publicado: (2022)

New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022)

Subgroup Classification of Myasthenia Gravis
por: Renjen, Pushpendra N.
Publicado: (2021)

Myasthenia gravis: A challenge
por: Ramesh, Bhagyalakshmi
Publicado: (2015)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
por: Schneider-Gold, Christiane, et al.
Publicado: (2017)

The perianaesthetic management of a patient with myasthenia gravis
por: Singh, Anisha, et al.
Publicado: (2023)

Electronic health record derived-impact of COVID-19 on myasthenia gravis
por: Roy, Bhaskar, et al.
Publicado: (2021)

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links
por: Singh, Shalendra, et al.
Publicado: (2022)

Management of thoracoscopic thymectomy in a myasthenia gravis patient
por: Adate, Kavita, et al.
Publicado: (2011)

Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.
por: Galassi, Giuliana, et al.
Publicado: (2021)

Nephrotic syndrome after thymectomy for myasthenia gravis
por: Kute, V. B., et al.
Publicado: (2013)

A Case of sporadic Creutzfeldt-Jakob disease
por: Şimşek, Fatma, et al.
Publicado: (2023)

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Emergency cesarian section in a patient of myasthenia gravis: Is neuraxial anesthesia safe?
por: Mundada, Surbhi D., et al.
Publicado: (2012)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Clinical characteristics and outcomes of patients with overlapping Miller Fisher syndrome and myasthenia gravis
por: Yuan, Jun-Liang, et al.
Publicado: (2019)

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
por: Tatar, Erhan, et al.
Publicado: (2020)

Primary Bacterial Ventriculitis caused by Staphylococcus warneri
por: Şimşek, Fatma, et al.
Publicado: (2023)

Rhinocerebral Mucormycosis After Tooth Extraction
por: Şimşek, Fatma, et al.
Publicado: (2023)

Sweet taste loss in myasthenia gravis: more than a coincidence?
por: Chabwine, Joelle N, et al.
Publicado: (2014)

Myasthenia Gravis Associated with Acute Hepatitis E Infection in Immunocompetent Woman
por: Belbezier, Aude, et al.
Publicado: (2014)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

COVID-19 in patients with myasthenia gravis
por: Kooli, Yosr, et al.
Publicado: (2021)

Acetylcholine Receptor-Antibody-Positive Myasthenia Gravis Presenting with Early Atrophy and Nonfluctuating Weakness of Proximal Limb Muscles
por: Pancheri, Elia, et al.
Publicado: (2020)

Systemic Lupus Erythematosus and Myasthenia Gravis in a Male Patient: an HLA Case Investigated
por: Klimi, Eleni, et al.
Publicado: (2021)

Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients
por: Chen, Ping-Jen, et al.
Publicado: (2021)

Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature
por: Aryani, Omid, et al.
Publicado: (2017)

Successful administration of electroconvulsive therapy in a patient with treatment-resistant schizophrenia and coexisting myasthenia gravis
por: Sreeraj, Vanteemar S., et al.
Publicado: (2019)

Cholinergic neuromuscular hyperactivity in a patient with anti-muscle-specific tyrosine kinase myasthenia gravis
por: Okhovat, Ali Asghar, et al.
Publicado: (2020)

Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
por: Korman, Tony M.
Publicado: (2021)

Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C
por: Amin, Saad Muhammad, et al.
Publicado: (2019)

A Randomized Control Study on the Efficacy of Thymectomy in Patients with Nonthymomatous (without Chest Tumor) Myasthenia Gravis
por: Chen, Ji, et al.
Publicado: (2020)

Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Le Panse, Rozen
Publicado: (2017)

Progressive Bulbar Palsy with Facial Diplegia and Proximal Weakness Diagnosed as Juvenile-Onset Myasthenia Gravis
por: Verma, Rajesh, et al.
Publicado: (2023)

Management of robotic partial nephrectomy in a patient with myasthenia gravis: General anaesthesia sans neuromuscular blocking agent
por: Ashokananda, Devanahalli, et al.
Publicado: (2022)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h36ftmkp2vjeujlm0nb0t00rl5